Jove
Visualize
Contact Us

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Tumor Progression02:07

Tumor Progression

6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  2. Ccz1 Accelerates The Progression Of Cervical Squamous Cell Carcinoma By Promoting Mmp2/mmp17 Expression.
  1. Home
  2. Ccz1 Accelerates The Progression Of Cervical Squamous Cell Carcinoma By Promoting Mmp2/mmp17 Expression.

Related Experiment Video

Zebrafish Model of Neuroblastoma Metastasis
05:20

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

2.8K

CCZ1 Accelerates the Progression of Cervical Squamous Cell Carcinoma by Promoting MMP2/MMP17 Expression.

Jing Yu1,2, Zhenlong Yuan1, Jing Liu1

  • 1Department of Gynecology Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.

Biomedicines
|July 27, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

CCZ1 is upregulated in cervical squamous cell carcinoma (CSCC), promoting tumor progression by increasing MMP2 and MMP17. This finding identifies CCZ1 as a potential biomarker and therapeutic target for CSCC.

Keywords:
CCZ1MMP17MMP2cervical squamous cell carcinoma

More Related Videos

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
07:26

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis

Published on: January 31, 2025

487
Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
04:20

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer

Published on: February 9, 2024

916

Related Experiment Videos

Zebrafish Model of Neuroblastoma Metastasis
05:20

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

2.8K
Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
07:26

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis

Published on: January 31, 2025

487
Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
04:20

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer

Published on: February 9, 2024

916

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cervical squamous cell carcinoma (CSCC) is a major health issue for women globally.
  • New biomarkers and therapeutic targets are crucial for improving CSCC patient outcomes.

Purpose of the Study:

  • To investigate the prognostic significance of CCZ1 in CSCC.
  • To elucidate the downstream pathways and targets regulated by CCZ1 in CSCC progression.

Main Methods:

  • Bioinformatic analysis of The Cancer Genome Atlas (TCGA) database (239 CSCC vs. 3 normal samples).
  • Immunohistochemical analysis of clinical CSCC samples.
  • In vitro functional assays (Cell Counting Kit-8, colony formation, Transwell, flow cytometry).
  • In vivo studies assessing tumor progression.
  • Gene knockdown and restoration experiments.
  • Main Results:

    • CCZ1 mRNA levels were significantly upregulated in CSCC tissues compared to normal tissues.
    • Elevated CCZ1 expression correlated with a poorer prognosis in CSCC patients.
    • CCZ1 knockdown inhibited CSCC cell proliferation, migration, invasion, and altered cell cycle progression.
    • CCZ1 knockdown suppressed CSCC progression both in vitro and in vivo.
    • CCZ1 knockdown led to decreased expression of MMP2 and MMP17.
    • Restoring MMP2 or MMP17 expression reversed the effects of CCZ1 knockdown.

    Conclusions:

    • CCZ1 promotes CSCC progression through the upregulation of MMP2 and MMP17.
    • CCZ1 serves as a novel prognostic biomarker for CSCC.
    • CCZ1 represents a potential therapeutic target for cervical squamous cell carcinoma treatment.